Hjertestatus skal undersøges før behandlingsstart og overvåges klinisk under behandling; ved eventuel forringelse skal behandlingen seponeres.
Cardiac status must be assessed before start of therapy and monitored clinically during therapy; if any deterioration occurs, therapy must be stopped.